AE Wealth Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.3M | Buy |
323,757
+79,618
| +33% | +$6.13M | 0.13% | 177 |
|
|
2025
Q4 | $19.4M | Sell |
244,139
-13,065
| -5% | -$1.03M | 0.11% | 192 |
|
|
2025
Q3 | $19.4M | Buy |
257,204
+14,983
| +6% | +$1.03M | 0.12% | 179 |
|
|
2025
Q2 | $16.7M | Buy |
242,221
+207,984
| +607% | +$13.6M | 0.12% | 183 |
|
|
2025
Q1 | $2.32M | Sell |
34,237
-9,737
| -22% | -$583K | 0.02% | 494 |
|
|
2024
Q4 | $1.97M | Buy |
43,974
+4,707
| +12% | +$264K | 0.02% | 525 |
|
|
2024
Q3 | $2.47M | Sell |
39,267
-16,849
| -30% | -$983K | 0.02% | 474 |
|
|
2024
Q2 | $3.31M | Buy |
56,116
+6,151
| +12% | +$385K | 0.03% | 416 |
|
|
2024
Q1 | $3.99M | Sell |
49,965
-189,512
| -79% | -$14.5M | 0.05% | 346 |
|
|
2023
Q4 | $17.5M | Sell |
239,477
-123,209
| -34% | -$8.77M | 0.09% | 265 |
|
|
2023
Q3 | $25.3M | Sell |
362,686
-9,810
| -3% | -$695K | 0.15% | 154 |
|
|
2023
Q2 | $25.8M | Buy |
372,496
+98,457
| +36% | +$7.01M | 0.15% | 149 |
|
|
2023
Q1 | $20.4M | Buy |
274,039
+20,819
| +8% | +$1.75M | 0.13% | 181 |
|
|
2022
Q4 | $23.6M | Sell |
253,220
-13,070
| -5% | -$1.26M | 0.17% | 145 |
|
|
2022
Q3 | $25.4M | Buy |
266,290
+31,606
| +13% | +$3.13M | 0.2% | 111 |
|
|
2022
Q2 | $21.7M | Buy |
234,684
+15,592
| +7% | +$1.52M | 0.17% | 141 |
|
|
2022
Q1 | $22.2M | Sell |
219,092
-3,331
| -1% | -$350K | 0.15% | 148 |
|
|
2021
Q4 | $22.9M | Buy |
222,423
+27,829
| +14% | +$2.57M | 0.16% | 130 |
|
|
2021
Q3 | $16.5M | Buy |
194,594
+48,920
| +34% | +$4.1M | 0.14% | 165 |
|
|
2021
Q2 | $12.2M | Buy |
145,674
+22,451
| +18% | +$1.84M | 0.11% | 192 |
|
|
2021
Q1 | $9.27M | Buy |
123,223
+24,095
| +24% | +$1.76M | 0.09% | 218 |
|
|
2020
Q4 | $6.77M | Buy |
99,128
+6,448
| +7% | +$419K | 0.08% | 234 |
|
|
2020
Q3 | $5.41M | Buy |
92,680
+4,881
| +6% | +$304K | 0.08% | 222 |
|
|
2020
Q2 | $5.7M | Buy |
87,799
+30,330
| +53% | +$1.91M | 0.09% | 205 |
|
|
2020
Q1 | $3.41M | Buy |
57,469
+24,629
| +75% | +$1.64M | 0.08% | 221 |
|
|
2019
Q4 | $2.44M | Buy |
32,840
+12,449
| +61% | +$874K | 0.05% | 300 |
|
|
2019
Q3 | $1.29M | Sell |
20,391
-1,458
| -7% | -$86.4K | 0.04% | 379 |
|
|
2019
Q2 | $1.19M | Buy |
21,849
+9,186
| +73% | +$495K | 0.04% | 356 |
|
|
2019
Q1 | $683K | Buy |
12,663
+6,913
| +120% | +$427K | 0.05% | 282 |
|
|
2018
Q4 | $377K | Buy |
5,750
+313
| +6% | +$23.4K | 0.06% | 298 |
|
|
2018
Q3 | $428K | Buy |
5,437
+1,620
| +42% | +$116K | 0.02% | 358 |
|
|
2018
Q2 | $246K | Sell |
3,817
-789
| -17% | -$52K | 0.02% | 377 |
|
|
2018
Q1 | $287K | Buy |
4,606
+1,802
| +64% | +$129K | 0.02% | 335 |
|
|
2017
Q4 | $203K | Sell |
2,804
-7,270
| -72% | -$529K | 0.02% | 394 |
|
|
2017
Q3 | $819K | Sell |
10,074
-611
| -6% | -$48.3K | 0.08% | 181 |
|
|
2017
Q2 | $860K | Buy |
10,685
+7,300
| +216% | +$576K | 0.1% | 167 |
|
|
2017
Q1 | $266K | Buy |
+3,385
| New | +$270K | 0.05% | 222 |
|
Other funds holding CVS
VCM
VPM
AE Wealth Management's CVS Position: Q1 2026 in Review
AE Wealth Management increased its CVS Health (CVS) stake by 33% in Q1 2026, buying an estimated $6.13M and bringing the position to 323,757 shares worth $23.3M. The position accounts for 0.13% of the portfolio, ranked #177.
AE Wealth Management first reported a position in CVS in Q1 2017 and has held it in 37 quarters since. The position peaked at $25.8M in Q2 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- AE Wealth Management held 323,757 shares of CVS Health worth $23.3M as of Q1 2026.
- AE Wealth Management bought 79,618 CVS Health shares in Q1 2026, an estimated $6.13M.
- CVS Health made up 0.13% of AE Wealth Management's portfolio in Q1 2026, its #177 holding.
- AE Wealth Management first reported a position in CVS Health in Q1 2017 and has held it in 37 quarters since.
- AE Wealth Management's CVS Health position peaked at $25.8M in Q2 2023.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.